Nucleic acid treatment of diseases or conditions related to levels of Ras

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20030153521A1
SERIAL NO

10238700

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to nucleic acid molecules, including enzymatic nucleic acid molecules, such as DNAzymes (e.g. DNA enzymes, catalytic DNA), that modulate the expression of Ras genes such as K-Ras, H-Ras, and/or N-Ras.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RIBOZYME PHARMACEUTICALS INC2950 WILDERNESS PLACE BOULDER CO 80301

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
McSwiggen, James Boulder, CO 332 8520

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation